Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fractyl Laboratories Inc.

www.fractyl.com

Latest From Fractyl Laboratories Inc.

Fractyl's Novel Diabetes Treatment Clears First Hurdle In Clinical Trial

The first-in-human study of Fractyl's Revita duodenal mucosal resurfacing system shows significant short-term improvement in hyperglycemia in patients with type 2 diabetes, with few adverse events.

Research & Development Clinical Trials

Investors Boost Metabolic Companies

Investments in endocrine/metabolic disease-focused medtech companies reached a four-year high in 2015. Biopharma companies grabbed the majority of the funds that have been raised since 2012, and among medtechs, those focused on diabetes fared best.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Laser
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Fractyl Laboratories Inc.
  • Senior Management
  • Harith Rajagopalan, MD, PhD, CEO
    Lisa Davidson, CFO
    Jay Caplan, Pres.
    Eric Bannon, VP, Regulatory & Clinical Affairs
  • Contact Info
  • Fractyl Laboratories Inc.
    203 Crescent St., Ste. 303
    Waltham, MA 02453
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register